Syngene International Ltd's Q3FY25 Quarter Results
- 24 Jan 2025
Result Summary
- Syngene International Ltd reported a 6.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 9.0%.
- Its expenses for the quarter were up by 1.4% QoQ and 5.4% YoY.
- The net profit increased 23.6% QoQ and increased 17.6% YoY.
- The earnings per share (EPS) of Syngene International Ltd stood at 3.3 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 962.00 | 907.50 | 882.80 | 6.0% | 9.0% |
Total Expenses | 781.20 | 770.20 | 740.90 | 1.4% | 5.4% |
Profit Before Tax | 180.80 | 137.30 | 138.20 | 31.7% | 30.8% |
Tax | 49.70 | 31.20 | 26.70 | 59.3% | 86.1% |
Profit After Tax | 131.10 | 106.10 | 111.50 | 23.6% | 17.6% |
Earnings Per Share | 3.30 | 2.60 | 2.80 | 26.9% | 17.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Syngene International Ltd is a leading contract research and manufacturing services company based in India. It operates within the biotechnology and pharmaceutical sectors, offering a wide range of integrated services that span the drug discovery and development continuum. The company provides these services to global pharmaceutical, biotechnology, and agrochemical companies. While specific recent developments are not detailed in the provided data, Syngene is known for its focus on innovation and collaboration, often forming strategic partnerships to enhance its service offerings. The company's reputation is built on its world-class research infrastructure and a skilled workforce that supports its clients in bringing complex therapies to market.
Revenue
In the third quarter of the fiscal year 2025 (Q3FY25), Syngene International Ltd reported a total income of ₹962.00 crores. This marks a 6.0% increase from the previous quarter (Q2FY25), where the total income was ₹907.50 crores. Compared to the same quarter last year (Q3FY24), the total income grew by 9.0%, rising from ₹882.80 crores. This upward trend in income reflects a consistent growth trajectory over both the quarter-on-quarter (QoQ) and year-on-year (YoY) periods. The data does not specify the sources of this income, such as the breakdown between service lines or geographic revenue contributions.
Profitability
Syngene International Ltd's profitability metrics for Q3FY25 show a robust performance. The company achieved a Profit Before Tax (PBT) of ₹180.80 crores, a significant increase of 31.7% from the previous quarter's ₹137.30 crores and a 30.8% increase from Q3FY24's ₹138.20 crores. After accounting for taxes, which rose by 59.3% QoQ to ₹49.70 crores, the company's Profit After Tax (PAT) stood at ₹131.10 crores. This represents a 23.6% increase over the previous quarter's PAT of ₹106.10 crores and a 17.6% increase compared to the same quarter last year, which was ₹111.50 crores. Earnings Per Share (EPS) followed a similar positive trend, increasing by 26.9% QoQ to ₹3.30 and by 17.9% YoY.
Operating Metrics
The operating metrics of Syngene International Ltd demonstrate an efficient cost management strategy, with total expenses for Q3FY25 recorded at ₹781.20 crores. This marks a modest increase of 1.4% from the previous quarter's expenses of ₹770.20 crores and a 5.4% rise from Q3FY24's expenses of ₹740.90 crores. The company's ability to control expense growth relative to income growth contributes to the enhanced profitability seen in this period. The financial data provided does not include detailed breakdowns of specific operational areas such as research and development costs or other operating expenses, which could further illustrate the company's operational efficiency.
